v3.26.1
Consolidated statement of comprehensive expense - EUR (€)
€ in Millions
12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2024
Consolidated statement of comprehensive income/(expense)      
(Loss)/profit for the financial year € (49) € (3,746) € 1,505
Items that may be reclassified to the income statement in subsequent years:      
Foreign exchange translation differences, net of tax (696) 321 (440)
Foreign exchange translation differences, transferred to the income statement 0 115 23
Other, net of tax [1] 209 36 (1,748)
Total items that may be reclassified to the income statement in subsequent years (487) 472 (2,165)
Items that will not be reclassified to the income statement in subsequent years:      
Fair value gains on equity instruments classified as Other investments, net of tax 428 116 0
Net actuarial gains/(losses) on defined benefit pension schemes, net of tax 9 1 (58)
Total items that will not be reclassified to the income statement in subsequent years 437 117 (58)
Other comprehensive (expense)/income (50) 589 (2,223)
Total comprehensive income/(expense) (99) (3,157) (718)
Attributable to:      
- Owners of the parent (254) (3,485) (920)
- Non-controlling interests 155 328 202
Total comprehensive income/(expense) € (99) € (3,157) € (718)
[1] Principally includes the impact of the Group’s cash flow hedges deferred to other comprehensive income during the year.